GKOS
Price:
$130.68
Market Cap:
$7.68B
Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to...[Read more]
Industry
Medical - Devices
IPO Date
2015-06-25
Stock Exchange
NYSE
Ticker
GKOS
According to Glaukos Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -39.60. This represents a change of -34.02% compared to the average of -60.02 of the last 4 quarters.
The mean historical PE Ratio of Glaukos Corporation over the last ten years is -948.14. The current -39.60 PE Ratio has changed 317.66% with respect to the historical average. Over the past ten years (40 quarters), GKOS's PE Ratio was at its highest in in the December 2016 quarter at 2.14K. The PE Ratio was at its lowest in in the March 2019 quarter at -517.39.
Average
-948.14
Median
-31.51
Minimum
-9500.00
Maximum
245.00
Discovering the peaks and valleys of Glaukos Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 89.31%
Maximum Annual PE Ratio = 245.00
Minimum Annual Increase = -3977.55%
Minimum Annual PE Ratio = -9500.00
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -34.42 | -36.41% |
| 2024 | -54.13 | 89.31% |
| 2023 | -28.59 | 36.81% |
| 2022 | -20.90 | -49.68% |
| 2021 | -41.53 | 49.00% |
| 2020 | -27.87 | -120.98% |
| 2019 | 132.85 | -187.51% |
| 2018 | -151.81 | -98.40% |
| 2017 | -9500.00 | -3977.55% |
| 2016 | 245.00 | -2213.61% |
The current PE Ratio of Glaukos Corporation (GKOS) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-39.05
5-year avg
-35.92
10-year avg
-948.14
Glaukos Corporation’s PE Ratio is less than TransMedics Group, Inc. (15.66), greater than iRhythm Technologies, Inc. (-121.69), less than Bausch + Lomb Corporation (-24.02), less than Merit Medical Systems, Inc. (28.60), greater than Bruker Corporation (-239.46), less than Alkermes plc (48.38), less than Arcellx, Inc. (-28.27), greater than Oscar Health, Inc. (-74.74), less than Arrowhead Pharmaceuticals, Inc. (-38.23), less than Teleflex Incorporated (-5.57),
| Company | PE Ratio | Market cap |
|---|---|---|
| 15.66 | $2.72B | |
| -121.69 | $3.44B | |
| -24.02 | $5.30B | |
| 28.60 | $4.01B | |
| -239.46 | $8.71B | |
| 48.38 | $7.50B | |
| -28.27 | $6.73B | |
| -74.74 | $7.36B | |
| -38.23 | $11.52B | |
| -5.57 | $5.62B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Glaukos Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Glaukos Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Glaukos Corporation's PE Ratio?
How is the PE Ratio calculated for Glaukos Corporation (GKOS)?
What is the highest PE Ratio for Glaukos Corporation (GKOS)?
What is the 3-year average PE Ratio for Glaukos Corporation (GKOS)?
What is the 5-year average PE Ratio for Glaukos Corporation (GKOS)?
How does the current PE Ratio for Glaukos Corporation (GKOS) compare to its historical average?